Rogocekib

DB21739InvestigationalSmall molecule

Rogocekib is a small molecule drug. Rogocekib has a monoisotopic molecular weight of 408.15 Da.

Mechanism: Pharmacologically active on Dual specificity protein kinase CLK1
Curator reviewed
Formula / weight: C₁₉H₁₇FN₈O₂ · 408.397 g/mol (avg)
Code names: CTX-712

Resolves to

Compound

Structure

InChIKeyOENNTZBJPRRGFL-SNVBAGLBSA-NSMILESCOC1=NC=NN2C=CC(=C12)C1=CN=C2N=C(C)N(CC3=NN=C(O3)[C@@H](C)F)C2=C1

Targets

What you can answer from here — as of September 13, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Rogocekib, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.